Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 10(6): e0131731, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26121471

RESUMO

Recent studies suggest the potential involvement of CD8+ T cells in the pathogenesis of murine hypertension. We recently reported that immunization with apoB-100 related peptide, p210, modified CD8+ T cell function in angiotensin II (AngII)-infused apoE (-/-) mice. In this study, we hypothesized that p210 vaccine modulates blood pressure in AngII-infused apoE (-/-) mice. Male apoE (-/-) mice were immunized with p210 vaccine and compared to unimmunized controls. At 10 weeks of age, mice were subcutaneously implanted with an osmotic pump which released AngII for 4 weeks. At 13 weeks of age, p210 immunized mice showed significantly lower blood pressure response to AngII compared to controls. CD8+ T cells from p210 immunized mice displayed a different phenotype compared to CD8+ T cells from unimmunized controls. Serum creatinine and urine albumin to creatinine ratio were significantly decreased in p210 immunized mice suggesting that p210 vaccine had renal protective effect. At euthanasia, inflammatory genes IL-6, TNF-α, and MCP-1 in renal tissue were down-regulated by p210 vaccine. Renal fibrosis and pro-fibrotic gene expression were also significantly reduced in p210 immunized mice. To assess the role of CD8+ T cells in these beneficial effects of p210 vaccine, CD8+ T cells were depleted by CD8 depleting antibody in p210 immunized mice. p210 immunized mice with CD8+ T cell depletion developed higher blood pressure compared to mice receiving isotype control. Depletion of CD8+ T cells also increased renal fibrotic gene expression compared to controls. We conclude that immunization with p210 vaccine attenuated AngII-induced hypertension and renal fibrosis. CD8+ T cells modulated by p210 vaccine could play an important role in the anti-hypertensive, anti-fibrotic and renal-protective effect of p210 vaccine.


Assuntos
Angiotensina II/efeitos adversos , Apolipoproteína B-100/imunologia , Hipertensão/etiologia , Hipertensão/prevenção & controle , Nefropatias/etiologia , Nefropatias/prevenção & controle , Peptídeos/imunologia , Animais , Apolipoproteína B-100/química , Pressão Sanguínea , Citocinas/metabolismo , Modelos Animais de Doenças , Fibrose , Expressão Gênica , Hipertensão/fisiopatologia , Imunização , Nefropatias/patologia , Depleção Linfocítica , Masculino , Camundongos , Camundongos Knockout , NADH NADPH Oxirredutases/metabolismo , NADPH Oxidase 1 , Peptídeos/administração & dosagem , Peptídeos/química , Espécies Reativas de Oxigênio , Subpopulações de Linfócitos T/imunologia , Subpopulações de Linfócitos T/metabolismo , Vacinas de Subunidades Antigênicas
2.
J Am Coll Cardiol ; 65(6): 546-56, 2015 Feb 17.
Artigo em Inglês | MEDLINE | ID: mdl-25677313

RESUMO

BACKGROUND: T cells and macrophages are implicated in the pathogenesis of aortic aneurysm (AA) and atherosclerosis. We recently demonstrated that a vaccine using an apoB-100-related peptide p210 reduces atherosclerosis with favorable modulation of CD8+ T cells in apolipoprotein E-deficient (apoE-/-) mice. OBJECTIVES: This study hypothesized that a p210 vaccine could reduce AA formation in the angiotensin II (Ang II)-induced AA model. METHODS: Male apoE-/- mice were immunized with p210 vaccine and implanted with an Ang II-releasing pump for 4 weeks. Flow cytometry assessed T cell activation and phenotype. Interleukin-6 (IL-6) and monocyte chemotactic protein 1 (MCP-1) expression were assessed using reverse transcription polymerase chain reaction. We used ex vivo aortic explants to test monocyte adhesion and in vitro cocultures to evaluate CD8+ T cell function. RESULTS: The p210 vaccine activated CD8+ T cells and reduced AA formation and mortality due to AA rupture, which was attenuated by CD8+ T cell depletion. Vaccination decreased expression of IL-6 and MCP-1 and reduced macrophage infiltration in the aorta. Cytotoxic T-lymphocyte assay showed that CD8+ T cells from p210-immunized mice had higher lytic activity against Ang II-stimulated macrophages. The p210 vaccine decreased splenic Th17 cells, and in vitro coculture of CD4+ and CD8+ T cells showed that CD8+ T cells from p210-immunized mice inhibited the polarization of CD4+ T cells into Th17 cells. IL-17A-/- mice infused with a higher dose of Ang II did not develop AA rupture. CONCLUSIONS: A p210 vaccine protected against Ang II-induced AA formation and mortality by reducing macrophage infiltration in the aorta and decreasing Th17 cell polarization. Our findings provide a potentially novel immunomodulating approach against AA.


Assuntos
Aneurisma Roto/prevenção & controle , Aneurisma da Aorta Abdominal/prevenção & controle , Apolipoproteína B-100/imunologia , Linfócitos T/imunologia , Vacinas/uso terapêutico , Aneurisma Roto/induzido quimicamente , Aneurisma Roto/imunologia , Angiotensina II/toxicidade , Animais , Aneurisma da Aorta Abdominal/induzido quimicamente , Aneurisma da Aorta Abdominal/imunologia , Modelos Animais de Doenças , Imunidade Celular , Macrófagos/imunologia , Masculino , Camundongos , Camundongos Knockout
3.
PLoS One ; 9(3): e92095, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24647529

RESUMO

BACKGROUND: The lipid milleu exacerbates the inflammatory response in atherosclerosis but its effect on T cell mediated immune response has not been fully elucidated. We hypothesized that lipid lowering would modulate T cell mediated immune function. METHODS AND RESULTS: T cells isolated from human PBMC or splenic T cells from apoE-/- mouse had higher proliferative response to T cell receptor (TCR) ligation in medium supplemented with 10% fetal bovine serum (FBS) compared to medium with 10% delipidated FBS. The differences in proliferation were associated with changes in lipid rafts, cellular cholesterol content, IL-10 secretion and subsequent activation of signaling molecule activated by TCR ligation. Immune biomarkers were also assessed in vivo using male apoE-/- mice fed atherogenic diet (AD) starting at 7 weeks of age. At 25 weeks of age, a sub-group was switched to normal diet (ND) whereas the rest remained on AD until euthanasia at 29 weeks of age. Dietary change resulted in a lower circulating level of cholesterol, reduced plaque size and inflammatory phenotype of plaques. These changes were associated with reduced intracellular IL-10 and IL-12 expression in CD4+ and CD8+ T cells. CONCLUSION: Our results show that lipid lowering reduces T cell proliferation and function, supporting the notion that lipid lowering modulates T cell function in vivo and in vitro.


Assuntos
Colesterol/metabolismo , Linfócitos T/imunologia , Animais , Apolipoproteínas E/deficiência , Apolipoproteínas E/metabolismo , Western Blotting , Proliferação de Células/efeitos dos fármacos , Separação Celular , Colesterol/sangue , Meios de Cultura/farmacologia , Gorduras na Dieta/farmacologia , Ensaio de Imunoadsorção Enzimática , Esterificação , Humanos , Interleucina-10/metabolismo , Ativação Linfocitária/efeitos dos fármacos , Masculino , Microdomínios da Membrana/efeitos dos fármacos , Microdomínios da Membrana/metabolismo , Camundongos Endogâmicos C57BL , Fosforilação/efeitos dos fármacos , Placa Aterosclerótica/patologia , Seio Aórtico/efeitos dos fármacos , Seio Aórtico/metabolismo , Seio Aórtico/patologia , Linfócitos T/citologia , Linfócitos T/efeitos dos fármacos , Proteína-Tirosina Quinase ZAP-70/metabolismo
4.
Biochem Biophys Res Commun ; 443(3): 864-70, 2014 Jan 17.
Artigo em Inglês | MEDLINE | ID: mdl-24342615

RESUMO

BACKGROUND: It is increasingly evident that CD8(+) T cells are involved in atherosclerosis but the specific subtypes have yet to be defined. CD8(+)CD25(+) T cells exert suppressive effects on immune signaling and modulate experimental autoimmune disorders but their role in atherosclerosis remains to be determined. The phenotype and functional role of CD8(+)CD25(+) T cells in experimental atherosclerosis were investigated in this study. METHODS AND RESULTS: CD8(+)CD25(+) T cells were observed in atherosclerotic plaques of apoE(-/-) mice fed hypercholesterolemic diet. Characterization by flow cytometric analysis and functional evaluation using a CFSE-based proliferation assays revealed a suppressive phenotype and function of splenic CD8(+)CD25(+) T cells from apoE(-/-) mice. Depletion of CD8(+)CD25(+) from total CD8(+) T cells rendered higher cytolytic activity of the remaining CD8(+)CD25(-) T cells. Adoptive transfer of CD8(+)CD25(+) T cells into apoE(-/-) mice suppressed the proliferation of splenic CD4(+) T cells and significantly reduced atherosclerosis in recipient mice. CONCLUSIONS: Our study has identified an athero-protective role for CD8(+)CD25(+) T cells in experimental atherosclerosis.


Assuntos
Apolipoproteínas E/deficiência , Aterosclerose/imunologia , Linfócitos T CD8-Positivos/imunologia , Subunidade alfa de Receptor de Interleucina-2/metabolismo , Transferência Adotiva , Animais , Apolipoproteínas E/metabolismo , Aterosclerose/sangue , Aterosclerose/patologia , Biomarcadores/metabolismo , Proliferação de Células , Dieta , Espaço Intracelular/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Fenótipo , Placa Aterosclerótica/sangue , Placa Aterosclerótica/imunologia , Placa Aterosclerótica/patologia , Baço/imunologia , Baço/patologia
5.
PLoS One ; 7(2): e30780, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22347402

RESUMO

Immunization of hypercholesterolemic mice with selected apoB-100 peptide antigens reduces atherosclerosis but the precise immune mediators of athero-protection remain unclear. In this study we show that immunization of apoE (-/-) mice with p210, a 20 amino acid apoB-100 related peptide, reduced aortic atherosclerosis compared with PBS or adjuvant/carrier controls. Immunization with p210 activated CD8(+) T cells, reduced dendritic cells (DC) at the site of immunization and within the plaque with an associated reduction in plaque macrophage immunoreactivity. Adoptive transfer of CD8(+) T cells from p210 immunized mice recapitulated the athero-protective effect of p210 immunization in naïve, non-immunized mice. CD8(+) T cells from p210 immunized mice developed a preferentially higher cytolytic response against p210-loaded dendritic cells in vitro. Although p210 immunization profoundly modulated DCs and cellular immune responses, it did not alter the efficacy of subsequent T cell dependent or independent immune response to other irrelevant antigens. Our data define, for the first time, a role for CD8(+) T cells in mediating the athero-protective effects of apoB-100 related peptide immunization in apoE (-/-) mice.


Assuntos
Antígenos/administração & dosagem , Apolipoproteína B-100/uso terapêutico , Aterosclerose/prevenção & controle , Linfócitos T CD8-Positivos/imunologia , Hipercolesterolemia/terapia , Transferência Adotiva , Animais , Antígenos/uso terapêutico , Apolipoproteína B-100/imunologia , Apolipoproteínas E/deficiência , Linfócitos T CD8-Positivos/transplante , Células Dendríticas , Imunização , Camundongos , Camundongos Knockout , Fragmentos de Peptídeos/imunologia , Fragmentos de Peptídeos/uso terapêutico , Substâncias Protetoras
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...